Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert F Smit

Showing results (221-230 of 367) with videos related to

Pageof 37
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2013
Adherence and patients' experiences with the use of oral anticancer agentsLonneke Timmers, Christel C L M Boons, Femke Kropff, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational statusIdris Bahce, Egbert F Smit, Mark Lubberink, et al.
International Journal of Oncology|July 3, 2010
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer ProjectRemco M Van den Berg, Hes Brokx, Aurélien Vesin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancerCorneline J Hoekstra, Sigrid G Stroobants, Egbert F Smit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patientsAstrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Clinical Lung Cancer|August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Journal of Extracellular Vesicles|December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancerJohannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesisRoderick H J Breuer, Peter J F Snijders, Egbert F Smit, et al.
Pageof 37

Showing results (221-230 of 367) with videos related to

Sort By:
Pageof 37
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2013
Adherence and patients' experiences with the use of oral anticancer agentsLonneke Timmers, Christel C L M Boons, Femke Kropff, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational statusIdris Bahce, Egbert F Smit, Mark Lubberink, et al.
International Journal of Oncology|July 3, 2010
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer ProjectRemco M Van den Berg, Hes Brokx, Aurélien Vesin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancerCorneline J Hoekstra, Sigrid G Stroobants, Egbert F Smit, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patientsAstrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Clinical Lung Cancer|August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Journal of Extracellular Vesicles|December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancerJohannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesisRoderick H J Breuer, Peter J F Snijders, Egbert F Smit, et al.
Pageof 37